OMERS Administration Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
OMERS Administration Corp's REGN Position: Q2 2026 in Review
OMERS Administration Corp increased its Regeneron Pharmaceuticals (REGN) stake by 23% in Q2 2026, buying an estimated $1.31M and bringing the position to 10,099 shares worth $6.3M. The position accounts for 0.04% of the portfolio, ranked #255.
OMERS Administration Corp first reported a position in REGN in Q3 2019 and has held it in 11 quarters since. The position peaked at $8.71M in Q3 2019. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- OMERS Administration Corp held 10,099 shares of Regeneron Pharmaceuticals worth $6.3M as of Q2 2026.
- OMERS Administration Corp bought 1,920 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.31M.
- Regeneron Pharmaceuticals made up 0.04% of OMERS Administration Corp's portfolio in Q2 2026, its #255 holding.
- OMERS Administration Corp first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 11 quarters since.
- OMERS Administration Corp's Regeneron Pharmaceuticals position peaked at $8.71M in Q3 2019.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.